top of page



Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator is a global nonprofit partnership focused on supporting the development of new antibacterial products. It is the world's largest public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria. With up to US$500 million to invest, CARB-X funds the best science around the world to accelerate the development of new antibiotics, vaccines, diagnostics and other life-saving products. The CARB-X portfolio is the world’s largest early development pipeline of new antibiotics, vaccines, rapid diagnostics and other products to prevent and treat life-threatening bacterial infections.

carb-x logo


The global accelerator network (GAN) of CARB-X is a network of accelerators around the world to provide scientific, technical and business support to CARB-X-funded product developers.

C-CAMP has been selected by CARB-X for its prestigious Global Accelerator Network (GAN), a league of 10 world-class organizations to combat anti-microbial resistance (AMR). C-CAMP is the only accelerator in the CARB-X GAN outside of USA and Europe.


GAN provides scientific, technical and business support to CARB-X-funded product developers around the world. The Network is a one-of-a-kind source of know-how and expertise in antibacterial drug development, diagnostics, business strategy and other areas essential to driving innovation and accelerating CARB-X’s growing portfolio of early development research projects.

CARB X map


Innovator school 2024


In vitro diagnostics

The fundamentals of IVD development – what they are, why they are important, & when you need to implement them.

Product development

Product development – concept, technical feasibility, and development stages


Infectious disease IVD development with an emphasis on diagnostics for bacteria and AMR

The Innovator School aims to train and equip academic innovators, entrepreneurs, early-stage companies, late-stage innovators and companies, with an improved understanding of the skills, principles, and systems required for effective vitro Diagnostics (IVD) product development. This training will help participants transition from academic & grant-based research to quality compliant product development. Participants will learn the FUNDAMENTALS for moving an IVD product from concept through development.


In Vitro Diagnostic (IVD) Product Development

On campus, Residential, C-CAMP, Bengaluru

Application Deadline: 22nd Jan 2023 

12th - 14th March 2023; 3 days

in vitro diagnostics


Past Cohorts

C-CAMP conducts annual idea challenges called C-CAMP AMR Quest as part of CARBX-GAN


Objective of the AMR Quest:

Identifying and rewarding innovative ideas and solutions in the AMR domain with a focus on ESKAPE pathogens and presenting opportunities for the development and commercialization of these.


  1. Acceptance into the 3-month C-CAMP AMR Accelerator Program. In this, an opportunity will be provided to develop the solution further with mentorship in the domains of science, business, regulatory, patent law, fundraising, etc.

  2. Investment opportunities for startups.

  3. Participation in International Conferences/Programs, with all costs covered

  4. Mentorship for seeking funding opportunities through the CARB-X funding round

  5. Opportunity for startups to participate in the C-CAMP Technology Showcase.

  6. Spotlight in C-CAMP's social media platforms.

  7. Opportunity to attend appropriate C-CAMP workshops & events.

DeepL BioX Innovation

Developing POC diagnostic solutions combining AI and devices.


Developing novel RNAi therapies to simultaneously clear antimicrobial resistant (AMR) infections and promote wound healing.


Achira's platform enables a microfluidics-based point-of-care(POC) platform ensuring frictionless, point of care testing.


A not-for-profit biotech R&D organization dedicated to infectious disease research.


A R&D based Indian company focusing on innovative and affordable products & solutions in the field of health care, biotechnology and various sectors of life sciences.

Geetika Dhanda, JNSCAR

RapidDX technologies

A Bangalore based young multi-disciplinary company developing a rapid Antimicrobial susceptibility test (AST) platform to reduce the time gap between sample collection and susceptibility detection.

Adiuvo Diagnostics

A technology-based social enterprise that focuses on creating platform technologies in the field of Opto- Electronics, with the objective of providing efficient assistance in early disease detection that is customized for low-resource settings.

PepThera Laboratories

PepThera Laboratories Private Limited is a Guwahati based start-up by alumni of Indian Institute of Technology Guwahati (IIT-Guwahati) and IIT-Indore. The vision of our company is to develop peptide-based therapeutic solutions for infectious and non-infectious diseases

Papyrus Diagnostics

An Indian Institute of Science based start-up with a mission of developing new technologies for point-of- care medical diagnostics and biomedical research for the low-resource settings of the world.


Developing antibody based solutions in 3 different formats, Camelid heavy chain fragments (VHH), Human scfv and mouse scfv.

Algorithmic Biologics

Algorithmic Biologics is bringing the power of algorithms to biotechnology based industries by building the information processing layer for biological data.


Offering solutions and services in cardiology, implantable devices, imaging diagnostics, laboratory diagnostics, radiology, critical care, & operating room equipment; with a vision of customizing the unaffordable medical technology for the underdeveloped communities across the globe.


A dynamic biotechnology company, that develops and commercializes diagnostic kits for pathogen detection and viral load monitoring, to empower labs to obtain reliable, timely, and actionable answers.


One of the first Indian companies using CRISPR-a breakthrough gene-editing technology-to develop high-quality diagnostic solutions in the life sciences that all Indians can afford.

Trana Labs

Developing novel methods for Biosimilars production. Systems with broad platform potential are being examined, with a focus on IP opportunities.

bottom of page